- Home
- Supplements
- Chromium Picolinate
- Hypoglycemia
Chromium Picolinate for Hypoglycemia
Small trials from the 1980s-90s suggested chromium may blunt reactive hypoglycaemia by improving insulin efficiency, but the evidence is old, small and never replicated at quality. Meal composition changes work far more reliably — and in anyone on diabetes medication, glucose-lowering supplements raise hypoglycaemia risk.
Overview
Verdict
How It Works
Dosing & Protocol
Typical dose
- Recommended dose
- 200-400 mcg/day of chromium picolinate with meals; older trials used up to 1000 mcg/day
- Expected timeframe
- 4-12 weeks
Protocol
- form
- Chromium picolinate
- step 1
- Get the diagnosis right first - document low glucose alongside symptoms, because true reactive hypoglycaemia is uncommon and most post-meal symptoms are not hypoglycaemia at all
- step 2
- Fix meal structure before supplementing: protein and fibre with every carbohydrate-containing meal, and avoid large refined-carbohydrate loads on an empty stomach
- timing
- With meals
- duration
- 8-12 weeks
- titration
- 400 mcg/day after 4 weeks if symptoms persist; older trials used up to 1000 mcg/day
- honest note
- A handful of small, old trials reported reduced reactive hypoglycaemia symptoms, but they predate modern methods and have not been replicated
- measurement
- A symptom-and-timing diary, ideally paired with glucose readings during symptomatic episodes
- starting dose
- 200 mcg/day with a meal
Evidence
What the studies say
Chromium picolinate does not improve key features of metabolic syndrome in obese nondiabetic adults
Iqbal N, Cardillo S, Volger S
CrPic at 1000 microg/day does not improve key features of the metabolic syndrome in obese nondiabetic patients.
Safety
Caveats
If you take insulin or a sulfonylurea, chromium can deepen hypoglycaemia rather than prevent it - do not start without your prescriber. Keep to 1000 mcg/day or below; high chronic doses have been linked in case reports to kidney failure, liver injury and rhabdomyolysis. Avoid in kidney or liver disease. Antacids reduce absorption; caution with levothyroxine and NSAIDs. Avoid high-dose use in pregnancy and breastfeeding. Recurrent documented hypoglycaemia in someone not on diabetes medication is a red flag requiring investigation for insulinoma, adrenal insufficiency and other causes.
Less likely to help if
Medical Disclaimer
The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.
Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.